Not applicableStudy completedNCT00900302What this trial is testingOX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With CancerWho this might be right forCancer OHSU Knight Cancer Institute 98
Testing effectiveness (Phase 2)Active Not RecruitingNCT04940299What this trial is testingTocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial CarcinomaWho this might be right forClinical Stage III Cutaneous Melanoma AJCC v8Clinical Stage IV Cutaneous Melanoma AJCC v8Locally Advanced Bladder Carcinoma+39 more M.D. Anderson Cancer Center 35
Early research (Phase 1)Study completedNCT04164069What this trial is testingDasatinib for the Prevention of Oxaliplatin-Induced Neuropathy in Patients With Metastatic Gastrointestinal Cancer Receiving FOLFOX Chemotherapy With or Without BevacizumabWho this might be right forAdvanced Colorectal CarcinomaMetastatic Colorectal CarcinomaStage IV Colorectal Cancer AJCC v8+13 more Anne Noonan 9
Not applicableWithdrawnNCT00084578What this trial is testingCelecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderWho this might be right forBladder Cancer Fox Chase Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06704191What this trial is testingIn-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE TrialWho this might be right forNon-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+1 more Mayo Clinic 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03601455What this trial is testingRadiation Therapy and Durvalumab With or Without Tremelimumab in Treating Participants With Unresectable, Locally Advanced, or Metastatic Bladder CancerWho this might be right forBladder Urothelial CarcinomaStage IV Bladder Cancer AJCC v8Stage IVA Bladder Cancer AJCC v8+1 more Jonsson Comprehensive Cancer Center 13
Testing effectiveness (Phase 2)Study completedNCT00556621What this trial is testingGemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder CancerWho this might be right forBladder Cancer Institut du Cancer de Montpellier - Val d'Aurelle 14
Not applicableStudy completedNCT01846520What this trial is testingFamily Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung CancersWho this might be right forHealthy SubjectLocalized Transitional Cell Cancer of the Renal Pelvis and UreterMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+81 more City of Hope Medical Center 200
Testing effectiveness (Phase 2)Study completedNCT00526656What this trial is testingSunitinib in Treating Patients With Locally Advanced Bladder CancerWho this might be right forBladder Cancer Case Comprehensive Cancer Center 9
Not applicableStudy completedNCT05025748What this trial is testingAsk Questions (ASQ):Implementation of a Communication InterventionWho this might be right forStage II Breast CancerStage III Breast CancerStage IV Breast Cancer+20 more Barbara Ann Karmanos Cancer Institute 81
Not applicableActive Not RecruitingNCT06350734What this trial is testingQuality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship StudyWho this might be right forStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8+2 more Mayo Clinic 204
Testing effectiveness (Phase 2)Study completedNCT03319745What this trial is testingPembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical CystectomyWho this might be right forStage I Bladder Cancer AJCC v8Stage II Bladder Cancer AJCC v8Stage III Bladder Cancer AJCC v8+2 more M.D. Anderson Cancer Center 23
Not applicableEnded earlyNCT02735512What this trial is testingMDSC Clinical Assay in Finding and Monitoring Cancer Cells in Blood and Urine Samples From Patients With or Without Localized or Metastatic Bladder CancerWho this might be right forNo Evidence of DiseaseStage II Bladder CancerStage III Bladder Cancer+2 more University of Southern California 10
Large-scale testing (Phase 3)Study completedNCT00033436What this trial is testingRadiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder CancerWho this might be right forBladder Cancer Mount Vernon Cancer Centre at Mount Vernon Hospital 330
Testing effectiveness (Phase 2)Looking for participantsNCT07061964What this trial is testingCombining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT TrialWho this might be right forMuscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8 National Cancer Institute (NCI) 111
Early research (Phase 1)Study completedNCT00002949What this trial is testingVinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the PelvisWho this might be right forBladder CancerCervical CancerEndometrial Cancer+1 more University of Chicago 33
Not applicableStudy completedNCT00900276What this trial is testingBiomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy ParticipantsWho this might be right forBladder CancerKidney CancerTransitional Cell Cancer of the Renal Pelvis and Ureter+1 more Wake Forest University Health Sciences 5
Testing effectiveness (Phase 2)Study completedNCT03513952What this trial is testingAtezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial CarcinomaWho this might be right forAdvanced Bladder Urothelial CarcinomaAdvanced Ureter Urothelial CarcinomaMetastatic Bladder Urothelial Carcinoma+21 more National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT04216290What this trial is testingChemotherapy and Radiation Therapy Compared to Chemotherapy and Radiation Therapy Plus MEDI4736 (Durvalumab) Immunotherapy for Bladder Cancer Which Has Spread to the Lymph Nodes, INSPIRE TrialWho this might be right forBladder Urothelial CarcinomaStage III Bladder Cancer AJCC v8 National Cancer Institute (NCI) 11
Testing effectiveness (Phase 2)Study completedNCT00002919What this trial is testingCombination Chemotherapy in Treating Patients With Stage II Bladder CancerWho this might be right forBladder Cancer Memorial Sloan Kettering Cancer Center 30